2/7/06 - At DEMO 2006, Colin Hill serves as a panelist for a Futurescan discussion about computational biology. (Feb. 6-8, Phoenix).
10/26/05 - GNS CEO Colin Hill delivers a presentation at Scientific American's
BioSilico 2005. (October 25-26, Cambridge, Mass.)
10/25/05 - At MEDi 2005, Colin Hill will
participate in a panel discussion about systems biology. (October 25-26, Hartford, Conn.)
9/26/05 - At CHI's Toxicity Biomarkers event in Philadelphia, Dr. Timothy Perera, Principal
Scientist in Oncology Discovery Research at Johnson & Johnson and GNS collaborator, will present
a talk covering the use of a systems biology approach for compound prioritization and elucidation
of mechanism of action.
9/9/05 - CEO Colin Hill will be presenting at Mary Crowley Medical Research Center's
Conference on the Gene Therapy of Cancer.
(Sept. 8-10, San Diego, CA)
8/9/05 - Vice President of R&D Iya Khalil will deliver a presentation on Modeling Issues in
Systems Biology, specifically looking at drug mechanism of action, at
Foundation of Systems Biology and Engineering (FOSBE) 2005 (August 7-10, Santa Barbara, CA)
6/16/05 - At CHI,s
Beyond Genome Conference, CEO Colin Hill will be
co-presenting with Dr. Gabriel Helmlinger, director of biological modeling of Novartis Pharma AG.
Their presentation is titled "Computational Methods For Determining Pathways and Biomarkers of Drugs
in Clinical Trials." (June 13-16, San Francisco, CA)
5/17/05 - At the
Bio-IT World Conference + Expo, Iya Khalil will present a speech on the
topic of Computational Systems Biology for Determining Biological Drug
Mechanism of Action. (May 17-19, Boston, MA)
5/11/05 - CEO Colin Hill will be addressing the value of pathways
and networks during the Target Assessment session at
PharmaDiscovery.
(May 10-12, Washington DC)
3/7-3/8/05 - Gene Network Sciences serves as a sponsor of
Communitech's Cancer Progress 2005 Conference.
(March 7-8, New York, NY)
1/18/05 - Iya Khalil, vice president of R&D, presents a talk at the RTK
Consortium's Systems
Biology of RTK Regulatory Networks Meeting entitled "Computationally
Driven Drug Development." (Jan. 17-19, Yokohama, Japan)
1/18/05 - At the
MITACS Biomedical Workshop, CEO Colin Hill will deliver a keynote
address. (Jan. 18-19, Montreal, Quebec, Canada)
9/20/04 - CEO Colin Hill delivers a talk at the
IBC Implementing Systems Biology Conference titled "Predictive Drug
Development Via Data-Driven Models of Cancer and Cardiovascular Systems."
(Sept. 20-22, Boston, MA, USA)
6/18/04 - Larry Felser, vice president of Technology Development, speaks
at 2nd
International E.Coli Alliance Conference on Systems Biology on "Tools
and Techniques for Modeling Cellular Processes." (June 18-22, Banff, Alberta,
Canada)
6/15/04 - At the
SMI Global Cancer Event, CEO Colin Hill delivers a presentation
entitled "Advances in Data-Driven Computer Modeling in Cancer Drug Discovery."
(June 14-15, London, UK)
4/27/04 - Iya Khalil, vice president of R&D, moderates a panel at
CBI's 2nd
Annual Forum on Combination Drug Therapies. (April 26-27, 2004,
Philadelphia, PA, USA)
3/8/04 - GNS is a supporting sponsor of the
Cancer Progress 2004 Conference, where Dr. Iya Khalil, GNS co-founder
and VP of R&D, is a panelist. (March 8-9, 2004, New York City, USA)
2/3/04 - GNS VP of R&D Iya Khalil speaks at the
CNIO (Centro Nacional de Investigaciones Oncolgicas) Symposium on
Applying fundamental advances in oncogenomics to the pathogenesis, diagnosis
and treatment of cancer. (February 3-6, 2004, Madrid, Spain)